{"id":49868,"date":"2022-10-20T16:02:34","date_gmt":"2022-10-20T14:02:34","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/"},"modified":"2022-10-20T16:02:34","modified_gmt":"2022-10-20T14:02:34","slug":"minnesota-experiencing-increase-in-illicit-fentanyl-exposure","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/","title":{"rendered":"Minnesota Experiencing Increase in Illicit Fentanyl Exposure"},"content":{"rendered":"
\n

\nMillennium Health Releases Emerging Threat Intelligence\u2122 Report<\/i> <\/b>to Help Prevent Opioid Overdoses<\/i>\n<\/p>\n

SAN DIEGO–(BUSINESS WIRE)–Millennium Health announced today that illicit fentanyl positivity in Minnesota increased by 400% in patient samples from substance use disorder treatment practices tested during the first half of 2022 compared to 2019. The company released its analysis of urine drug test (UDT) results to help raise community awareness and education.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nA dramatic increase in drug overdose deaths is being reported across the U.S. According to the CDC, Minnesota overdose deaths increased over 71% between 2019 and 2021 compared to a 51% increase nationwide.1 <\/sup>Contributing to these deaths is the unsuspected presence of illicit fentanyl in counterfeit pills and other substances, such as cocaine.2<\/sup>\n<\/p>\n

\nA previous study by Millennium Health published in JAMA Network Open<\/i> found that UDT results were highly correlated with mortality rates at national, state, and county levels.3<\/sup> Reporting on UDT results showing increased positivity for fentanyl may help sound an alert sooner and save lives.\n<\/p>\n

\n\u201cWe have already seen too many Minnesota families lose loved ones to drugs. Our goal is to work hand-in-hand with public health and safety authorities, health care providers, and community organizations to proactively address drug exposures and help prevent drug overdose deaths,\u201d said Angela G. Huskey, PharmD, CPE, Chief Clinical Officer at Millennium Health.\n<\/p>\n

\nAdditional information regarding real-time substance use trends is available here<\/a>.\n<\/p>\n

\nAbout Millennium Health<\/span><\/b>\n<\/p>\n

\nMillennium Health<\/a> is an accredited specialty laboratory providing medication monitoring via definitive urine<\/a> and oral fluid<\/a> drug tests to support improved clinical decision-making as part of treatment for millions of Americans with chronic pain, mental illness, substance use disorders, and other health conditions. Drug testing<\/a> is used to obtain objective information about patients\u2019 recent use of prescription medications and\/or illicit drugs and helps monitor the effectiveness of treatment plans. We also conduct real-time tracking of emerging drug use trends<\/a> to help researchers, public health officials, and policymakers address the significant increase in drug overdose deaths.\n<\/p>\n

\nReferences\n<\/p>\n

    \n
  1. \nProvisional Drug Overdose Death Counts. National Center for Health Statistics. Centers for Disease Control and Prevention Web site. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm<\/a>. Accessed October 2022.\n<\/li>\n
  2. \nUS Drug Enforcement Administration. One Pill Can Kill. DEA reveals criminal drug networks are flooding the U.S with deadly fentanyl. https:\/\/www.dea.gov\/onepill<\/a>. Accessed April 2022.\n<\/li>\n
  3. \nWhitley P, LaRue L, Fernandez SA, et al. Analysis of Urine Drug Test Results From Substance Use Disorder Treatment Practices and Overdose Mortality Rates, 2013-2020. JAMA Netw Open. 2022;5(6):e2215425.\n<\/li>\n<\/ol>\n

    \n\u00a0\n<\/p>\n

    Contacts<\/b> <\/p>\n

    \nJody Schneider, Millennium Health
    \n
    (619) 917-6810
    \n
    Jody.Schneider@millenniumhealth.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    Millennium Health Releases Emerging Threat Intelligence\u2122 Report to Help Prevent Opioid Overdoses SAN DIEGO–(BUSINESS WIRE)–Millennium Health announced today that illicit fentanyl positivity in Minnesota increased by 400% in patient samples from substance use disorder treatment practices tested during the first half of 2022 compared to 2019. The company released its analysis of urine drug test … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49868","6":"format-standard","7":"category-industry"},"yoast_head":"\nMinnesota Experiencing Increase in Illicit Fentanyl Exposure - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Minnesota Experiencing Increase in Illicit Fentanyl Exposure - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Millennium Health Releases Emerging Threat Intelligence\u2122 Report to Help Prevent Opioid Overdoses SAN DIEGO–(BUSINESS WIRE)–Millennium Health announced today that illicit fentanyl positivity in Minnesota increased by 400% in patient samples from substance use disorder treatment practices tested during the first half of 2022 compared to 2019. The company released its analysis of urine drug test ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-20T14:02:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221020005373\/en\/1608389\/21\/MLH-361-V01_Minnesota_Fentanyl_Infographic_FINAL.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Minnesota Experiencing Increase in Illicit Fentanyl Exposure\",\"datePublished\":\"2022-10-20T14:02:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\\\/\"},\"wordCount\":425,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221020005373\\\/en\\\/1608389\\\/21\\\/MLH-361-V01_Minnesota_Fentanyl_Infographic_FINAL.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\\\/\",\"name\":\"Minnesota Experiencing Increase in Illicit Fentanyl Exposure - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221020005373\\\/en\\\/1608389\\\/21\\\/MLH-361-V01_Minnesota_Fentanyl_Infographic_FINAL.jpg\",\"datePublished\":\"2022-10-20T14:02:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221020005373\\\/en\\\/1608389\\\/21\\\/MLH-361-V01_Minnesota_Fentanyl_Infographic_FINAL.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221020005373\\\/en\\\/1608389\\\/21\\\/MLH-361-V01_Minnesota_Fentanyl_Infographic_FINAL.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Minnesota Experiencing Increase in Illicit Fentanyl Exposure\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Minnesota Experiencing Increase in Illicit Fentanyl Exposure - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/","og_locale":"en_US","og_type":"article","og_title":"Minnesota Experiencing Increase in Illicit Fentanyl Exposure - Pharma Trend","og_description":"Millennium Health Releases Emerging Threat Intelligence\u2122 Report to Help Prevent Opioid Overdoses SAN DIEGO–(BUSINESS WIRE)–Millennium Health announced today that illicit fentanyl positivity in Minnesota increased by 400% in patient samples from substance use disorder treatment practices tested during the first half of 2022 compared to 2019. The company released its analysis of urine drug test ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-20T14:02:34+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221020005373\/en\/1608389\/21\/MLH-361-V01_Minnesota_Fentanyl_Infographic_FINAL.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Minnesota Experiencing Increase in Illicit Fentanyl Exposure","datePublished":"2022-10-20T14:02:34+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/"},"wordCount":425,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221020005373\/en\/1608389\/21\/MLH-361-V01_Minnesota_Fentanyl_Infographic_FINAL.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/","url":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/","name":"Minnesota Experiencing Increase in Illicit Fentanyl Exposure - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221020005373\/en\/1608389\/21\/MLH-361-V01_Minnesota_Fentanyl_Infographic_FINAL.jpg","datePublished":"2022-10-20T14:02:34+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221020005373\/en\/1608389\/21\/MLH-361-V01_Minnesota_Fentanyl_Infographic_FINAL.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221020005373\/en\/1608389\/21\/MLH-361-V01_Minnesota_Fentanyl_Infographic_FINAL.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/minnesota-experiencing-increase-in-illicit-fentanyl-exposure\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Minnesota Experiencing Increase in Illicit Fentanyl Exposure"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49868"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49868\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49868"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49868"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}